DK2131841T3 - Fremgangsmåder til behandling af akut smerte - Google Patents

Fremgangsmåder til behandling af akut smerte

Info

Publication number
DK2131841T3
DK2131841T3 DK08724934.8T DK08724934T DK2131841T3 DK 2131841 T3 DK2131841 T3 DK 2131841T3 DK 08724934 T DK08724934 T DK 08724934T DK 2131841 T3 DK2131841 T3 DK 2131841T3
Authority
DK
Denmark
Prior art keywords
methods
acute pain
treating acute
treating
pain
Prior art date
Application number
DK08724934.8T
Other languages
English (en)
Inventor
Linda Watkins
Mark Hutchinson
Kirk W Johnson
Original Assignee
Avigen Inc
Univ Colorado Regents
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Avigen Inc, Univ Colorado Regents filed Critical Avigen Inc
Application granted granted Critical
Publication of DK2131841T3 publication Critical patent/DK2131841T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK08724934.8T 2007-01-30 2008-01-29 Fremgangsmåder til behandling af akut smerte DK2131841T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US89836207P 2007-01-30 2007-01-30
PCT/US2008/001187 WO2008094571A1 (en) 2007-01-30 2008-01-29 Methods for treating acute and subchronic pain

Publications (1)

Publication Number Publication Date
DK2131841T3 true DK2131841T3 (da) 2012-10-15

Family

ID=39345258

Family Applications (1)

Application Number Title Priority Date Filing Date
DK08724934.8T DK2131841T3 (da) 2007-01-30 2008-01-29 Fremgangsmåder til behandling af akut smerte

Country Status (8)

Country Link
US (1) US20080181876A1 (da)
EP (1) EP2131841B1 (da)
DK (1) DK2131841T3 (da)
ES (1) ES2392116T3 (da)
HK (1) HK1139856A1 (da)
PL (1) PL2131841T3 (da)
PT (1) PT2131841E (da)
WO (1) WO2008094571A1 (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2623072A1 (en) * 2005-09-26 2007-04-05 Avigen, Inc. Use of ibudilast for treating drug and behavioral addictions
EP2026804A1 (en) 2006-05-31 2009-02-25 Avigen, Inc. Ibudilast for inhibiting macrophage migration inhibitory factor (mif) activity
CA2669463A1 (en) * 2006-11-09 2008-05-15 Avigen, Inc. Method for treating delirium
WO2008137012A1 (en) * 2007-05-03 2008-11-13 Avigen, Inc. Use of a glial attenuator to prevent amplified pain responses caused by glial priming
CA2785056A1 (en) 2009-12-22 2011-07-21 Pondera Biotechnologies, LLC Methods and compositions for treating distress dysfunction and enhancing safety and efficacy of specific medications
US9980900B2 (en) 2015-12-22 2018-05-29 Revogenex Ireland Ltd Intravenous administration of tramadol
US9693949B1 (en) 2015-12-22 2017-07-04 Revogenex Ireland Ltd Intravenous administration of tramadol
WO2019148047A1 (en) * 2018-01-25 2019-08-01 Cognifisense, Inc. Combinatorial therapeutic systems and methods
US11977085B1 (en) 2023-09-05 2024-05-07 Elan Ehrlich Date rape drug detection device and method of using same

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5229318B2 (da) 1972-03-30 1977-08-01
US4097483A (en) 1974-11-01 1978-06-27 Kyorin Pharmaceutical Co., Ltd. Pyrazolo 1,5-a!pyridines
JPS6263520A (ja) * 1985-09-14 1987-03-20 Kyorin Pharmaceut Co Ltd 抗リウマチ剤
CA2224517A1 (en) * 1995-06-12 1996-12-27 G.D. Searle & Co. Compositions comprising a cyclooxygenase-2 inhibitor and a 5-lipoxygenase inhibitor
US20040014761A1 (en) * 1997-10-28 2004-01-22 Place Virgil A. Treatment of female sexual dysfunction with phosphodiesterase inhibitors
ES2324540T3 (es) 1998-05-27 2009-08-10 Genzyme Corporation Vectores aav para la fabricacion de medicamentos para la administracion potenciada por conveccion.
CA2319495A1 (en) * 1998-06-08 1999-12-16 Advanced Medicine, Inc. Multibinding inhibitors of microsomal triglyceride transferase protein
JP4828003B2 (ja) * 1998-08-10 2011-11-30 杏林製薬株式会社 多発性硬化症治療薬
US20020068740A1 (en) * 1999-12-07 2002-06-06 Mylari Banavara L. Combination of aldose reductase inhibitors and antihypertensive agents for the treatment of diabetic complications
US7135495B2 (en) * 2000-03-09 2006-11-14 Ono Pharmaceutical Co., Ltd. Indole derivatives
WO2001074811A2 (en) * 2000-03-30 2001-10-11 Takeda Chemical Industries, Ltd. Substituted 1,3-thiazole compounds, their production and use
GB0008269D0 (en) * 2000-04-05 2000-05-24 Astrazeneca Ab Combination chemotherapy
KR100884709B1 (ko) * 2000-09-14 2009-02-19 미쓰비시 타나베 파마 코퍼레이션 신규한 아미드 유도체의 광학 활성체 및 그의 의약적 용도
DE20020546U1 (de) * 2000-12-04 2002-04-11 Zumtobel Staff Gmbh, Dornbirn Fassung für Kompaktleuchtstofflampen
US20020137755A1 (en) * 2000-12-04 2002-09-26 Bilodeau Mark T. Tyrosine kinase inhibitors
US20040063685A1 (en) * 2000-12-08 2004-04-01 Juji Ilzawa Combination Drugs
US20040097555A1 (en) * 2000-12-26 2004-05-20 Shinegori Ohkawa Concomitant drugs
US20050080113A1 (en) * 2001-06-11 2005-04-14 Shigenori Ohkawa Medicinal compositions
CA2451288A1 (en) * 2001-07-31 2003-02-13 Pharmacia & Upjohn Company Treatment of chronic pain with 3-heterocyclyl- and 3-cycloalkyl-3-aryloxypropanamines
WO2003013513A1 (en) * 2001-08-03 2003-02-20 Takeda Chemical Industries, Ltd. Stable emulsion composition
WO2003014110A1 (fr) * 2001-08-08 2003-02-20 Takeda Chemical Industries, Ltd. Derive de benzazepine, son procede de preparation et d'utilisation
US7022689B2 (en) * 2001-08-09 2006-04-04 Kissei Pharmaceutical Co., Ltd. 5-amidino-n-(2-aminophenethyl)-n-hydroxy-benzenesulffonamide derivative, medical composition containing the same, pharmaceutical use thereof and intermediate therefor
US7338939B2 (en) * 2003-09-30 2008-03-04 New River Pharmaceuticals Inc. Abuse-resistant hydrocodone compounds
JP4292402B2 (ja) * 2001-09-07 2009-07-08 小野薬品工業株式会社 インドール誘導体化合物、それらの製造方法およびそれらを有効成分として含有する薬剤
JPWO2003040086A1 (ja) * 2001-11-09 2005-03-03 キッセイ薬品工業株式会社 ５−アミジノ−２−ヒドロキシベンゼンスルホンアミド誘導体、それを含有する医薬組成物、その医薬用途およびその製造中間体
IL163866A0 (en) * 2002-03-05 2005-12-18 Ono Pharmaceutical Co 8-Azaprostaglandin derivative compounds and drugs containing the compounds s active ingredient
US20040053842A1 (en) * 2002-07-02 2004-03-18 Pfizer Inc. Methods of treatment with CETP inhibitors and antihypertensive agents
US20050038063A1 (en) * 2002-11-29 2005-02-17 Kenneth Newman Method of treating acute pain with unitary dosage form comprising ibuprofen and oxycodone
CL2004000545A1 (es) * 2003-03-18 2005-01-28 Pharmacia Corp Sa Organizada B Uso de un antagonista de los receptores de aldosterona y un antagonista de receptores de endotelina para el tratamiento o profilaxis de una condicion patologica relacionada con hipertension, disfuncion renal, insulinopatia y enfermedades cardiovascul
CL2004000544A1 (es) * 2003-03-18 2005-01-28 Pharmacia Corp Sa Organizada B Uso de una combinacion farmaceutica, de un antagonista del receptor de aldosterona y un inhibidor de endopeptidasa neutral, util para el tratamiento y prevencion de una condicion patologica relacionada con hipertension, disfuncion renal, insulinopati
US20040266743A1 (en) * 2003-05-09 2004-12-30 Pharmacia Corporation Combination of an aldosterone receptor antagonist and a renin inhibitor
US7261882B2 (en) * 2003-06-23 2007-08-28 Reagents Of The University Of Colorado Methods for treating neuropathic pain by administering IL-10 polypeptides
TW200517114A (en) * 2003-10-15 2005-06-01 Combinatorx Inc Methods and reagents for the treatment of immunoinflammatory disorders
US7534806B2 (en) * 2004-12-06 2009-05-19 Avigen, Inc. Method for treating neuropathic pain and associated syndromes
MX2007015789A (es) * 2005-06-16 2008-02-15 Mallinckrodt Inc Nueva ruta de sintesis para opiatos de 14-hidroxilo a traves de 1-halo-tebaina o analogos.
CA2623072A1 (en) * 2005-09-26 2007-04-05 Avigen, Inc. Use of ibudilast for treating drug and behavioral addictions
EP2026804A1 (en) * 2006-05-31 2009-02-25 Avigen, Inc. Ibudilast for inhibiting macrophage migration inhibitory factor (mif) activity
JP5352452B2 (ja) * 2006-06-06 2013-11-27 メディシノバ， インコーポレイテッド 置換ピラゾロ［１，５−ａ］ピリジン化合物およびその使用方法
CA2669463A1 (en) * 2006-11-09 2008-05-15 Avigen, Inc. Method for treating delirium

Also Published As

Publication number Publication date
EP2131841A1 (en) 2009-12-16
WO2008094571A1 (en) 2008-08-07
US20080181876A1 (en) 2008-07-31
PL2131841T3 (pl) 2013-03-29
HK1139856A1 (en) 2010-09-30
EP2131841B1 (en) 2012-08-01
ES2392116T3 (es) 2012-12-04
PT2131841E (pt) 2012-09-24

Similar Documents

Publication Publication Date Title
LTPA2016041I1 (lt) Gydymo būdai panaudojant vaistus - amoniako gaudykles
BRPI0814359A2 (pt) Método
BRPI0817226A2 (pt) Método
BRPI0817726A2 (pt) Método
BRPI0810206A2 (pt) Método de tratar câncer
BRPI0910854A2 (pt) métodos de tratamento
DK2212070T3 (da) Fremgangsmåde til behandling af træ
DK2310034T3 (da) Peptider til behandling af beta-amyloidose
DK2293816T3 (da) Fremgangsmåder til behandling af reumatoid arthritis
DK2203551T3 (da) Bifidobakterieart
DK3289876T3 (da) Forbindelser til behandling af cancer
BRPI0919127A2 (pt) métodos para tratamento de água
BRPI0813670A2 (pt) Compostos para tratamento
DK2131841T3 (da) Fremgangsmåder til behandling af akut smerte
DK2330887T3 (da) Behandlingsindretning
DK2342346T3 (da) Thermotoga til behandling af biomasse
DK2173831T3 (da) Brøndbehandling
BRPI0821652A2 (pt) tratamento de biocombustíveis
DK2164572T3 (da) Carbamoyl-cyclohexaner til behandling af akut mani
BRPI0809678A2 (pt) Métodos
DK2441462T3 (da) Fremgangsmåde til behandling af type I-diabetes
BRPI0810416A2 (pt) Método de hidroformação
BRPI0916818A2 (pt) Método para tratamento de dentes sensíveis
DK2215314T3 (da) Indretning til behandling af regnvand
DK2012814T3 (da) Fremgangsmåder til behandling af autoimmunsygdomme